Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Microbiota, inflammation and obesity.

Sanz Y, Moya-Pérez A.

Adv Exp Med Biol. 2014;817:291-317. doi: 10.1007/978-1-4939-0897-4_14.

PMID:
24997040
[PubMed - in process]
2.

High protein diet modifies colonic microbiota and luminal environment but not colonocyte metabolism in the rat model: The increased luminal bulk connection.

Liu X, Blouin JM, Santacruz A, Lan A, Andriamihaja M, Wilkanowicz S, Benetti PH, Tomé D, Sanz Y, Blachier F, Davila AM.

Am J Physiol Gastrointest Liver Physiol. 2014 Jun 26. pii: ajpgi.00400.2013. [Epub ahead of print]

PMID:
24970777
[PubMed - as supplied by publisher]
3.

The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease.

Olivares M, Neef A, Castillejo G, Palma GD, Varea V, Capilla A, Palau F, Nova E, Marcos A, Polanco I, Ribes-Koninckx C, Ortigosa L, Izquierdo L, Sanz Y.

Gut. 2014 Jun 17. pii: gutjnl-2014-306931. doi: 10.1136/gutjnl-2014-306931. [Epub ahead of print]

PMID:
24939571
[PubMed - as supplied by publisher]
4.

Role of Interleukin 10 in norfloxacin prevention of luminal free endotoxin translocation in mice with cirrhosis.

Gómez-Hurtado I, Moratalla A, Moya-Pérez A, Peiró G, Zapater P, González-Navajas JM, Giménez P, Such J, Sanz Y, Francés R.

J Hepatol. 2014 May 29. pii: S0168-8278(14)00378-X. doi: 10.1016/j.jhep.2014.05.031. [Epub ahead of print]

PMID:
24882049
[PubMed - as supplied by publisher]
5.

Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease.

Olivares M, Castillejo G, Varea V, Sanz Y.

Br J Nutr. 2014 Jul;112(1):30-40. doi: 10.1017/S0007114514000609. Epub 2014 Apr 28.

PMID:
24774670
[PubMed - in process]
6.

Antibiotic exposure in pregnancy and risk of coeliac disease in offspring: a cohort study.

Mårild K, Ludvigsson J, Sanz Y, Ludvigsson JF.

BMC Gastroenterol. 2014 Apr 14;14:75. doi: 10.1186/1471-230X-14-75.

PMID:
24731164
[PubMed - in process]
Free PMC Article
7.

Combining motivational and volitional strategies to promote unsupervised walking in patients with fibromyalgia: study protocol for a randomized controlled trial.

Pastor MÁ, López-Roig S, Lledó A, Peñacoba C, Velasco L, Schweiger-Gallo I, Cigarán M, Ecija C, Limón R, Sanz Y.

Trials. 2014 Apr 11;15:120. doi: 10.1186/1745-6215-15-120.

PMID:
24721143
[PubMed - in process]
Free PMC Article
8.

Human milk composition differs in healthy mothers and mothers with celiac disease.

Olivares M, Albrecht S, De Palma G, Ferrer MD, Castillejo G, Schols HA, Sanz Y.

Eur J Nutr. 2014 Apr 4. [Epub ahead of print]

PMID:
24700375
[PubMed - as supplied by publisher]
9.

Protective effect of Bifidobacterium pseudocatenulatum CECT7765 against induced bacterial antigen translocation in experimental cirrhosis.

Moratalla A, Gómez-Hurtado I, Santacruz A, Moya A, Peiró G, Zapater P, González-Navajas JM, Giménez P, Such J, Sanz Y, Francés R.

Liver Int. 2014 Jul;34(6):850-8. doi: 10.1111/liv.12380. Epub 2013 Nov 24.

PMID:
24267920
[PubMed - in process]
10.

Future for probiotic science in functional food and dietary supplement development.

Neef A, Sanz Y.

Curr Opin Clin Nutr Metab Care. 2013 Nov;16(6):679-87. doi: 10.1097/MCO.0b013e328365c258. Review.

PMID:
24071779
[PubMed - indexed for MEDLINE]
11.

Probiotics and clinical effects: is the number what counts?

Bertazzoni E, Donelli G, Midtvedt T, Nicoli J, Sanz Y.

J Chemother. 2013 Aug;25(4):193-212. doi: 10.1179/1973947813Y.0000000078. Review.

PMID:
23906073
[PubMed - indexed for MEDLINE]
12.

Duodenal-mucosal bacteria associated with celiac disease in children.

Sánchez E, Donat E, Ribes-Koninckx C, Fernández-Murga ML, Sanz Y.

Appl Environ Microbiol. 2013 Sep;79(18):5472-9. doi: 10.1128/AEM.00869-13. Epub 2013 Jul 8.

PMID:
23835180
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Hepatic molecular responses to Bifidobacterium pseudocatenulatum CECT 7765 in a mouse model of diet-induced obesity.

Moya-Pérez A, Romo-Vaquero M, Tomás-Barberán F, Sanz Y, García-Conesa MT.

Nutr Metab Cardiovasc Dis. 2014 Jan;24(1):57-64. doi: 10.1016/j.numecd.2013.04.011. Epub 2013 Jul 4.

PMID:
23831006
[PubMed - in process]
14.

Influence of early environmental factors on lymphocyte subsets and gut microbiota in infants at risk of celiac disease; the PROFICEL study.

Pozo-Rubio T, de Palma G, Mujico JR, Olivares M, Marcos A, Acuña MD, Polanco I, Sanz Y, Nova E.

Nutr Hosp. 2013 Mar-Apr;28(2):464-73. doi: 10.3305/nh.2013.28.2.6310.

PMID:
23822699
[PubMed - indexed for MEDLINE]
Free Article
15.

Oral administration of Bifidobacterium longum CECT 7347 ameliorates gliadin-induced alterations in liver iron mobilisation.

Laparra JM, Olivares M, Sanz Y.

Br J Nutr. 2013 Nov;110(10):1828-36. doi: 10.1017/S0007114513001098. Epub 2013 May 9.

PMID:
23657133
[PubMed - indexed for MEDLINE]
16.

Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice.

Cano PG, Santacruz A, Trejo FM, Sanz Y.

Obesity (Silver Spring). 2013 Nov;21(11):2310-21. doi: 10.1002/oby.20330. Epub 2013 May 29.

PMID:
23418126
[PubMed - in process]
17.

Host genotype, intestinal microbiota and inflammatory disorders.

Olivares M, Laparra JM, Sanz Y.

Br J Nutr. 2013 Jan;109 Suppl 2:S76-80. doi: 10.1017/S0007114512005521. Review.

PMID:
23360883
[PubMed - indexed for MEDLINE]
18.

Re-print of "Intestinal luminal nitrogen metabolism: role of the gut microbiota and consequences for the host".

Davila AM, Blachier F, Gotteland M, Andriamihaja M, Benetti PH, Sanz Y, Tomé D.

Pharmacol Res. 2013 Mar;69(1):114-26. doi: 10.1016/j.phrs.2013.01.003. Epub 2013 Jan 12.

PMID:
23318949
[PubMed]
19.

Intestinal luminal nitrogen metabolism: role of the gut microbiota and consequences for the host.

Davila AM, Blachier F, Gotteland M, Andriamihaja M, Benetti PH, Sanz Y, Tomé D.

Pharmacol Res. 2013 Feb;68(1):95-107. doi: 10.1016/j.phrs.2012.11.005. Epub 2012 Nov 24. Review.

PMID:
23183532
[PubMed - indexed for MEDLINE]
20.

Understanding the role of gut microbes and probiotics in obesity: how far are we?

Sanz Y, Rastmanesh R, Agostoni C.

Pharmacol Res. 2013 Mar;69(1):144-55. doi: 10.1016/j.phrs.2012.10.021. Epub 2012 Nov 9. Erratum in: Pharmacol Res. 2013 May;71:69. Agostonic, Carlo [corrected to Agostoni, Carlo].

PMID:
23147032
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk